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Background: The fatty acid (FA) composition of the red blood cell (RBC) has been reported to provide
prognostic information regarding risk for coronary heart disease (CHD). In particular, the Omega-3
Index (RBC eicosapentaenoic acidþdocosahexaenoic acid, EPAþDHA) has been shown to be indepen-
dently and inversely related to risk for sudden cardiac death and for acute coronary syndromes. Higher
linoleic acid (n-6) and lower trans FA levels have also been associated with improved CHD outcomes.
Accordingly, the RBC FA panel has recently been introduced in routine clinical laboratory testing.
Objective: The purpose of this study was to deﬁne age- and gender-based norms for RBC FA levels.
Methods: RBC FA proﬁles from about 160,000 patients (48% from males, 52% from females) were
measured at Health Diagnostic Laboratory. These data were used to create age decade and gender-
speciﬁc norms (percentiles). FA values were expressed as a percent of total identiﬁed FA.
Results: Compared to men, women generally had higher C18 trans levels, and between the ages of
10–29 years, they had DHA and lower EPA levels. Among the major FA classes, saturated (41% of total)
and trans (0.85%) fats did not vary appreciably by age, whereas monounsaturated fats tended to rise
slightly. Of the two major n-6 polyunsaturates, arachidonic and linoleic acids, the former was
unchanged across decades (16.4% abundance) whereas the latter decreased by about 2 percentage
points (13.0–11.1%). The overall median Omega-3 Index was 4.5%, and across the decades it increased
by about 1.5 percentage points. The Omega-3 Index and linoleic acid stabilized after age 70.
Conclusion: Whereas RBC saturated, mono- and polyunsaturated FA levels are generally stable across
the lifespan, there is a shift in the composition of the latter, with an increase in the Omega-3 Index and
a decrease in linoleic acid. Higher DHA and lower EPA levels in younger women is consistent with
enhanced conversion of EPA to DHA during the early reproductive years. The availability of RBC FA
norms will facilitate research into the relationships between altered FA status and human disease, and
will help physicians evaluate the n-3 FA status of their patients.
& 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Red blood cell (RBC) membrane fatty acid composition is
determined by a combination of diet and metabolism. All major
classes of fatty acids are found in RBC—saturated, monounsatu-
rated, trans unsaturated, and polyunsaturated (both n-3 and n-6
families). Much interest has focused on the marine n-3 fatty acids,
eicosapentaenoic and docosahexaenoic acids (EPA and DHA,
respectively; the sum of which is the Omega-3 Index) [1], as
reduced levels in both the diet and in RBC membranes have been
associated with a higher cardiovascular disease (CVD) risk proﬁle
[2], increased risk for CVD [3,4] and neuropsychiatric [5] diseases,
accelerated cellular aging [6] and early mortality [7]. Since these226; fax: þ1 804 343 2704.
is).
Y-NC-ND license.associations are largely independent of other known risk factors,
and because the Omega-3 Index is an easily, safely and inexpen-
sively treated risk factor, clinical laboratories have begun to offer
testing. Accordingly, it is important to establish age- and sex-
based norms against which practitioners can evaluate their
patients. The purpose of this study was to deﬁne those values
for a large and unselected cohort of patients whose blood was
submitted for testing at a commercial laboratory.2. Methods
2.1. Subjects
Data for this study was obtained from blood samples sub-
mitted for testing to Health Diagnostic Laboratory, Inc. (HDL,
Table 1
Sample size by gender and decade of life.
Decade Total Men Women
10s 1153 503 650
20s 5948 2580 3368
30s 14,464 7017 7447
40s 28,545 14,393 14,152
50s 39,430 19,368 20,062
60s 37,991 18,196 19,795
70s 22,695 10,442 12,253
80s 8561 3581 4980
90s 984 351 633
Total 159,771 76,431 (48%) 83,340 (52%)
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linked patient identiﬁers. Age and gender were the only demo-
graphic data available. IRB approval for these types of studies
(using de-identiﬁed and aggregated laboratory data) was
obtained from the Copernicus Group (Durham, NC).
In an effort to address the question of how representative of
the general population this convenience patient sample was, RBC
fatty acid composition of an age- and gender-matched subset of
HDL data was compared to that of the Framingham cohort [2].
Additional comparisons were made with recent data from the
National Health and Nutrition Examination Survey (NHANES)
derived from 1806 randomly selected US adults between 2003
and 2006 [8]. As the NHANES reported plasma fatty acid concen-
trations and not RBC fatty acid percent composition, the former
were converted into plasma fatty acid percent composition (a
closer surrogate of the RBC metric) by summing the plasma
concentrations across all fatty acids and then calculating each
fatty acids’ percent of total. Although plasma and RBC fatty acid
compositions are numerically different, for the essential n-6 and
n-3 fatty acids they are relatively well-correlated (r¼0.6–0.8)
[9]. Trends in plasma essential fatty acid composition across the
lifespan from NHANES were then compared to trends observed in the
HDL cohort.
2.2. Laboratory methods
RBC fatty acid composition was analyzed according to the
HS-Omega-3 Indexs methodology as modiﬁed from Harris et al.
[10] Fatty acid methyl esters were generated from erythrocytes
by transesteriﬁcation with boron triﬂuoride and analyzed by gas
chromatography. Fatty acids were identiﬁed by comparison with
a standard mixture of fatty acids characteristic of RBCs. Omega-3
index results are given as EPA plus DHA expressed as a percentage
of total identiﬁed fatty acids after response factor correction
(based on calibration curves) was applied to each fatty acid. The
CV for the Omega-3 Index assay was o3.5%.
2.3. Statistical methods
Percentiles were calculated for individual and groups of fatty
acids. Percentiles were also calculated by age decade, and gender
for the Omega-3 Index. Stratiﬁed (by age decade and gender)
random sampling was used to match a subset of the HDL patients
to the Framingham cohort for comparison of fatty acid values.
Since most of the fatty acid distributions were right-skewed, a
natural logarithm transformation was used to improve the nor-
mality and homogeneity assumptions required for parametric
general linear models. The mean of the log-transformed data (i.e.,
geometric mean) was tested for gender differences (Z5% relative
effect size) in each age decade using t-tests. Linear trends (Z1%
relative change per decade) were tested using piece-wise linear
regression with a break (i.e., knot) at 70 years. The estimated
effects were exponentiated and reported as relative percent changes
in fatty acids. Due to the very large sample size, meaningful effect
sizes (noted above) were used in combination with a Bonferroni
adjusted critical level of 0.05/10 tests¼0.005 for each fatty acid to
ascribe statistical signiﬁcance. Analyses were performed using SASs
software (version 9.2; SAS Institute).3. Results
Information on RBC fatty acid composition was available from
about 160,000 individual patients measured between July 2011
and April 2012 (see Table 1 for sample sizes by decade and
gender). Teenagers through nonagenarians were represented,with females slightly outnumbering males. Population ranges
and variability in RBC fatty acid content were estimated using
percentile values (from the 1st to the 99th) for the major fatty
acids of interest the population coefﬁcients of variation (Table 2).
Total saturated and total polyunsaturated fatty acids had the least
between-person variability, with coefﬁcients of variation o5%.
Mean levels of arachidonic acid (the primary n-6 fatty acid in
RBC membranes), total polyunsaturated and saturated fatty acid
compositions remained very stable across the lifespan, and there
were no gender differences (Fig. 1, total saturated not shown).
Monounsaturated fatty acid levels increased a small extent over
the ﬁrst seven decades. The mean levels of the 18-carbon (C18)
trans fatty acids were relatively ﬂat through the 60s but increased
slightly thereafter. Total n-6 polyunsaturated fatty acids
decreased between the teens and 70s due primarily to a 3% per
decade fall in linoleic acid levels. Total n-3 fatty acids increased
across the same time fame because of increases in EPA (13% per
decade), docosapentaenoic acid (DPA) (3% per decade), and DHA
(6% per decade). There was a signiﬁcant decrease in the mean
levels of EPA (9% per decade) and DPA (1% per decade) after
age 70. The net effect on the Omega-3 Index was an overall
increase of about 7% per decade up thru 70 years, with little
change thereafter. The percentile distributions for the Omega-3
Index by decade of life for men and women combined are shown
in Fig. 2.
Gender-based differences were observed in all the n-3 and in
the C18 trans fatty acids (Fig. 1). Mean EPA and DPA levels were
reduced in women compared to men through the 40s and DHA
was increased for women in their teens and twenties. ALA levels
were higher in women than men by about 5% relative amounts
across all ages. During the 30s through 50s, trans levels were
slightly higher in women vs. men.
The Framingham cohort was used as a relatively normative
comparator group and included 3196 individuals, 9% of which
were minorities and 45% of which were male. Their mean (SD) age
was 66 (9) years. The Framingham erythrocyte samples were
obtained during 2005–2007, whereas the HDL samples were
collected between 2011 and 2012. Framingham cohort and the
HDL subgroup that was matched by age and gender with it, had
very similar erythrocyte fatty acid proﬁles (Table 3). The largest
differences were seen in a few very low-abundance fatty acids
including C18:1 trans oleic acid and the sphingolipid-associated
fatty acids [C24:0 (lignoceric acid) and C24:1 (nervonic acid)].4. Discussion
The primary question addressed in this study was, ‘‘do RBC
fatty acid patterns vary with age and/or gender?’’ As such, this
was a descriptive study that included data from about 160,000
people with ages between 10 and 99 years. This is the largest
Table 2
Percentiles of major RBC fatty acids (N¼159,771).
Fatty Acids (as a proportion of total) 1st 5th 25th 50th 75th 95th 99th CV
Alpha-linolenic acid (n-3)a 0.10 0.10 0.12 0.14 0.16 0.23 0.30 30.6
Eicosape docosapentaenoic acid (DPA) ntaenoic acid (n-3) 0.19 0.25 0.36 0.50 0.84 1.94 3.19 84.4
Docosapentaenoic acid (n-3) 1.61 1.88 2.25 2.53 2.88 3.61 4.17 20.3
Docosahexaenoic acid (n-3) 1.87 2.33 3.17 4.04 5.18 7.02 8.30 34.0
Omega-3 Index 2.20 2.70 3.60 4.50 6.00 8.80 11.10 38.8
Linoleic acid (n-6) 7.66 8.78 10.46 11.65 12.86 14.72 16.28 15.7
Arachidonic acid (n-6) 11.42 12.99 14.93 16.11 17.23 18.78 19.87 11.0
N3 PUFA 4.40 5.10 6.10 7.10 8.90 12.30 15.00 29.7
N6 PUFA 26.00 28.80 32.50 34.60 36.10 38.00 39.20 8.2
PUFA 37.80 39.10 40.80 41.90 43.00 44.50 45.60 4.0
Saturated fats 38.50 39.40 40.50 41.30 42.40 43.70 44.50 3.2
Monounsaturated fats 12.90 13.70 14.90 15.70 16.60 18.00 19.30 8.3
C18 Trans 0.46 0.57 0.74 0.87 1.03 1.36 1.73 28.3
CV¼between patients coefﬁcient of variation.
a N¼126,628.
-3.0%
1.3%
4.8%
7.2%
6.2%
2.7%
-1.2%
13%
-8.8%
Fig. 1. Geometric mean RBC fatty acid levels (as a % of total) in 159,771 patients by decade of life (columns) and by sex (male, solid lines; females, dashed lines).%po0.005
males vs. females and 45% relative difference. The arrows and associated percents refer to the direction and magnitude of change on a relative % per decade basis displayed for
only those fatty acids than changed by 41% per decade (po0.0001). The vertical axis scales were chosen to show a doubling (or halving) effect if it occurred.
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such, can have value in establishing norms for use in the clinic,
at least in the US. These individuals were all being evaluated
by their physicians for cardiovascular risk factors as a part of
normal clinical care, and therefore, these ﬁndings may apply only
to such individuals, and the extent to which they describe the
‘‘typical American’’ is unknown. A comparison with the Framing-
ham cohort was undertaken to shed some light on this question,
and the remarkable similarity in RBC fatty acid compositionbetween these two cohorts – despite being collected 6 years
apart – suggests that the data from the HDL patient cohort is
reasonably generalizable in the US.
4.1. Relations with age
The mean levels of the major fatty acid classes (saturated,
monounsaturated and polyunsaturated) were generally constant
across the lifespan. This consistency and the low between-person
Fig. 2. Percentiles of the Omega-3 Index by decade (genders combined). Lines at 4% and 8% indicate high and low cardiovascular risk [1] levels, respectively.
Table 3
Comparison of RBC fatty acid composition in the Framinghama cohort (from
2006) versus an age and gender frequency matched subgroup of HDL patients
(from 2011).
Variable Framingham HDL Fold
differenceN¼3196 N¼86,012
Mean (SD) Mean (SD)
Myristic, C14:0 0.31 (0.08) 0.24 (0.08) 1.29
Palmitic, C16:0 21.29 (1.24) 21.27 (1.21) 1.00
Stearic, C18:0 18.11 (0.95) 18.03 (1.38) 1.00
Lignoceric, C24:0 0.43 (0.16) 1.21 (0.49) 2.81
Palmitoleic, C16:1 0.35 (0.19) 0.29 (0.18) 1.21
Oleic, C18:1 13.88 (1.06) 14.24 (1.19) 1.03
Eicosenoic, C20:1 0.27 (0.11) 0.28 (0.06) 1.04
Nervonic, C24:1 0.45 (0.15) 1.16 (0.45) 2.58
trans Oleic, C18:1 trans 1.62 (0.55) 0.66 (0.24) 2.45
trans Linoleic, C18:2 trans 0.25 (0.08) 0.25 (0.06) 1.00
trans Palmitoleic, C16:1 trans 0.17 (0.05) 99% o0.1b n/a
Linoleic, C18:2n6 11.19 (1.74) 11.41 (1.84) 1.02
gamma-Linolenic, C18:3n6 0.08 (0.09) 84% o0.1 n/a
Eicosadienoic, C20:2n6 0.28 (0.05) 0.30 (0.05) 1.07
Eicosatrienoic, C20:3n6 1.59 (0.36) 1.69 (0.41) 1.06
Arachidonic, C20:4n6 16.78 (1.62) 15.99 (1.85) 1.05
Docosatetraenoic, C22:4n6 3.76 (0.83) 3.54 (0.90) 1.06
Docosapentaenoic, C22:5n6 0.66 (0.19) 0.61 (0.21) 1.08
Alpha-Linolenic, C18:3n3 0.19 (0.10) 0.15 (0.05) 1.27
Eicosapentaenoic (EPA),
C20:5n3
0.74 (0.46) 0.80 (0.66) 1.08
Docosapentaenoic, C22:5n3 2.74 (0.46) 2.66 (0.56) 1.03
Docosahexaenoic (DHA),
C22:6n3
4.88 (1.38) 4.50 (1.48) 1.08
Omega-3 Index (EPAþDHA)a 5.62 (1.71) 5.30 (2.02) 1.06
a Framingham data reprinted with permission from Harris et al. [2].
b detection limit was 0.1%.
Fig. 3. Mean daily intakes (g/day) of alpha-linolenic acid (ALA), docosahexaenoic
acid (DHA), eicosapentaenoic acid (EPA), and linoleic acid (LA) (top to bottom) by
decade of age for females and males from NHANES 2009 to 2010 (N¼7027).
W.S. Harris et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 88 (2013) 257–263260variability suggest homeostatic mechanisms are at work. Although
consumed in relatively large quantities in the diet, the saturated
and monounsaturated fatty acids are also synthesized de novo
which may explain why both plasma and RBC membrane content
of these fatty acids do not correlate strongly with intake [11]. As
regards the polyunsaturated fatty acids, the overall constant meanlevel obscures changes that occur within the two subgroups: the
n-6 and n-3 fatty acids. The major n-6 fatty acid in the RBC
membrane, arachidonic acid (16% of total), was remarkably stable
over time and had little inter-individual variability (CV¼11%).
Arachidonic is derived from the diet and synthesis from linoleic
acid (although synthesis rates have been reported to be o1% [12]).
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affect plasma phospholipid arachidonic acid levels [13]. The
NHANES-reported linoleic acid intakes of around 16 g per day
represents about 7% of total energy intake, and given that required
intakes of this essential fatty acid are 1–2% of energy [14], dietary
linoleate availability is not rate limiting for arachidonate synthesis,
therefore metabolic factors must determine membrane AA levels.
For its part, linoleic acid levels were inversely associated with age,
decreasing about 3% per year up until age 70. A similar trend was
seen in the plasma fatty acid data from NHANES [8]. The plasma
linoleic acid percent dropped across the lifespan, e.g., from 32.7%
(20–39 years) to 31.6% (40–59 years) to 30.5% (459 years). The
reasons for the inverse relations between age and RBC linoleic acid
levels, also observed by others [15–17], are not clear. One obvious
explanation would be a change in linoleate intake. However, dietary
data from NHANES (2009–2010) show stable intakes of this fatty
acid between the teens and the 50s; intakes start to decrease at
about the same time that RBC linoleate levels stablize (cf.
Figs. 3 and 1) [18]. Other potential explanations for this effect are
discussed below.
In concert with the decreasing linoleic acid content in RBCs we
observed increasing EPA and DHA levels. This relationship
between age and long-chain n-3 fatty acid levels (i.e., the
Omega-3 Index) has been reported several times before with
smaller data sets [19–26]. Plasma EPAþDHA levels from NHANES
show a similar tendency to rise across the lifespan, e.g., from 1.4%
(20–39 years) to 1.5% (40–59 years) to 1.6% (459 years). A
variety of forces could be operating here. Most obviously, increas-
ing intakes (both dietary and supplementary) of EPA and DHA
could contribute. The amount of EPA and DHA consumed by the
individuals in the current study is unknown; however the most
recent NHANES dietary data [18] (2009–2010) indicate that the
intake of EPA and DHA from food (not supplements, which is not
available) does appear to increase with age through the 50s,
similar to the trend seen in the RBC (cf. Figs. 3 and 1). Consistent
with this observation, some investigators have reported that the
rise in this biomarker with age is linked with dietary changes
[15,27], whereas others have reported the rise to be independent
of n-3 intake [2,15–17,19]. The rise in the Omega-3 Index with
age could be secondary to an increasing ALA intake, but this is
also generally stable across the lifespan (Fig. 3) as were RBC ALA
levels (Fig. 1). While very large increases in dietary linoleic acid
(e.g., increasing from 5 g/d to 36 g/d) can reduce the incorporation
of supplemental EPA and DHA into plasma and tissues [28,29], a
more physiologic increase (e.g., going from 8 g/d to 16 g/d) does
not affect membrane n-3 content [30]. Hence, the variations in
population linoleic acid intake across the lifespan would not be
expected to impact n-3 fatty acid levels. On the other hand, in
supplementation studies with EPA and DHA, linoleic blood levels
are often reduced as the n-3 fatty acid levels increase [31–34], so
higher n-3 fatty acid levels can lower linoleic levels. This is likely
due to competition between these polyunsaturated fatty acids for
incorporation into the 2-position of phospholipids. On balance, it
seems more likely that the rise in the n-3 fatty acids is the cause
of the decrease in linoleate, and not vice versa.
Cunnane and colleagues have explored the n-3 fatty acid—age
relationship in some detail. They have reported that elderly
individuals respond to supplemental EPA and DHA with a greater
rise in plasma DHA (RBC not tested) than young people [35], and
that labeled DHA is cleared from plasma lipids (especially from
the triglyceride and non-esteriﬁed fatty acid compartments) more
slowly in the elderly, but overall oxidation of DHA is not different
between old and young [36]. Consequently, changes in underlying
fatty acid metabolism may be playing a role. Another possible
explanation for a rising Omega-3 Index with age is ‘‘the attrition
of the susceptible.’’ Since a lower blood n-3 fatty acid level isassociated with increased risk for death in randomized trials
[37–39], and in some [7,40–43] but not all [40,41,44–47] pro-
spective cohort studies, it is possible that the rise in the Omega-3
Index with age is an artifact, a result of the premature demise of
younger individuals with lower levels. Hence, aging may not raise
blood n-3 levels; but higher n-3 levels may promote longevity
[6,7]. This explanation is suspect, however, since the apparent rise
with age is most evident (and steady) between the teens and the
60s, and is ﬂat from the 70s on. Since most deaths occur in the
latter group, one would expect that a mortality effect would be
most striking in the older, not younger, people. At present, the
reason for the direct association between age and the Omega-3
Index is an increasing intake with age.
Trans fatty acid levels (about 1.0% of total RBC fatty acids) are
relatively unrelated to age, and are considerably lower than they
were in Framingham both in 1999 (2.4%) and in 2006 (1.8%) [10].
This suggests that the continuing efforts of the food industry
(under government and health organization pressure) to refor-
mulate vegetable oils to remove trans fatty acids has been
successful in reducing the burden of these fatty acids in tissues.
Greater intrinsic (i.e., metabolic) control of membrane fatty
acid composition would be reﬂected in lower inter-individual
variability in RBC fatty acid levels (which can be expressed as
coefﬁcients of variation, CV). Greater dietary inﬂuence on com-
position would be reﬂected in higher CVs. This ﬁts the observa-
tions made here where the largest CVs were seen with the n-3
and trans fatty acids, and the smallest with saturated, monoun-
saturated and omega-6 fatty acids (especially arachidonic acid).
4.2. Relations by gender
The higher population CVs observed for the n-3 and trans fatty
acids, are partially due to gender differences. There were differ-
ences for EPA and DHA: in young women (teens and 20s), EPA
was lower and DHA was higher than in young men. Women have
been reported to have higher DHA levels in some studies
[2,24,27,48] but not in others [15,26,49]. Conversion of alpha-
linolenic acid to DHA may be higher in young women than men
[50], likely driven by sex hormones [51]. In older women, the
current study did not detect a gender difference in the Omega-3
Index whereas there was a small difference in Framingham,
where the mean age is 67 years [2], which suggests that hormonal
effects may not be completely responsible. Of course there could
be a dietary etiology as well, and NHANES data do show lower
EPA and DHA intakes in young women vs. men (Fig. 3). However,
differences in DHA intake in this age range do not explain the
higher RBC DHA content in young women. However, NHANES
intake data are not adjusted for body weight.
This study has strengths and limitations. Among the former
are large sample size encompassing nine decades of life with an
even mix of men and women. Limitations include the lack of
information on dietary and other clinical/demographic data from
these subjects. The RBC fatty acid values observed here are likely
speciﬁc to the US, and possibly other westernized countries; they
would not be normative for other countries, particularly in Japan
[21] and Korea [52], where ﬁsh consumption is higher.5. Conclusion
RBC fatty acid data observed from over 160,000 outpatients in
late 2011–early 2012 provide an estimate of ‘‘normal’’ values for
these analytes across the lifespan for a US population. Although
most fatty acid levels are stable, the Omega-3 Index is directly,
and linoleic acid is inversely, related to age. Trans fatty acid levels
in this study are considerably lower than they were in earlier
W.S. Harris et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 88 (2013) 257–263262studies suggesting that continuing national efforts to reduce
consumption of trans fats and to remove trans fatty acids from
food products has met with some success. Young women have
higher DHA levels than young men, which likely represents
enhanced conversion of EPA to DHA during the early reproductive
years. The availability of RBC fatty acid normative values will
facilitate research into the relationships between altered fatty
acid status and human disease, and will help physicians evaluate
the n-3 fatty acid status of their patients across age and gender
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